PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Microsoft, Silvercloud to “pioneer” AI in mental health

SilverCloud Health and Microsoft have embarked on a research collaboration to further enhance the digital mental health company’s online offering with artificial intelligence (AI).

SilverCloud announced that the companies’ labs in Cambridge have been working together over the past 18 months, in research that combines Microsoft’s cutting-edge machine learning and AI technologies with SilverCloud’s expertise in real-world delivery of evidence-based interventions and mental health outcomes.

The collaboration will use machine learning and artificial intelligence to “accelerate the understanding and delivery of personalised mental healthcare that responds to each patient’s unique situation,” including early interventions to optimise clinical outcomes, thereby ensuring patients have access to the right support and content at the right time and in the right context.

“SilverCloud Health is one of the very few digital mental health platforms that has been deployed at scale in routine clinical care, and currently has the largest real-world patient user base of its kind,” said Christopher Bishop, lab director, Microsoft Research, Cambridge, UK.

He continued to say that the aim of the project is “very much aligned to our ambition to empower healthcare workers and patients through access to effective, intelligent technologies.”

SilverCloud’s digital mental health platform is used across 75% of NHS mental health services in IAPT (Improving Access to Psychological Therapies) and over 250 organisations globally.

With over one million hours of therapy delivered since spinning out from research in 2012, the breadth of the platform’s data provides a “unique opportunity” for the deep research collaboration, and will help to change how online therapy is delivered for the NHS.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026